,48 As the AML-inducing compartment is described by a CD34+/CD38−/+/CD123+ immunophenotype,4,45,49 targeting CD123 potentially enables sustained responses in patients due to eradication of LICs. Here, CD34 is linked to acute myeloid leukemia.